39 related articles for article (PubMed ID: 11309361)
1. Reduction in surface urokinase receptor forces malignant cells into a protracted state of dormancy.
Yu W; Kim J; Ossowski L
J Cell Biol; 1997 May; 137(3):767-77. PubMed ID: 9151680
[TBL] [Abstract][Full Text] [Related]
2. Human antibody V
Chu X; Li W; Hines MG; Lyakhov I; Mellors JW; Dimitrov DS
Front Oncol; 2023; 13():1194972. PubMed ID: 37876962
[TBL] [Abstract][Full Text] [Related]
3. The use of adenoviral vectors in gene therapy and vaccine approaches.
Araújo NM; Rubio IGS; Toneto NPA; Morale MG; Tamura RE
Genet Mol Biol; 2022; 45(3 Suppl 1):e20220079. PubMed ID: 36206378
[TBL] [Abstract][Full Text] [Related]
4. Urokinase-type plasminogen activator receptor (uPAR) as a therapeutic target in cancer.
Zhai BT; Tian H; Sun J; Zou JB; Zhang XF; Cheng JX; Shi YJ; Fan Y; Guo DY
J Transl Med; 2022 Mar; 20(1):135. PubMed ID: 35303878
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic Strategies Targeting Urokinase and Its Receptor in Cancer.
Masucci MT; Minopoli M; Di Carluccio G; Motti ML; Carriero MV
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158766
[TBL] [Abstract][Full Text] [Related]
6. The Urokinase Receptor: A Multifunctional Receptor in Cancer Cell Biology. Therapeutic Implications.
Li Santi A; Napolitano F; Montuori N; Ragno P
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33923400
[TBL] [Abstract][Full Text] [Related]
7. Semaphorin 6A Attenuates the Migration Capability of Lung Cancer Cells via the NRF2/HMOX1 Axis.
Chen LH; Liao CY; Lai LC; Tsai MH; Chuang EY
Sci Rep; 2019 Sep; 9(1):13302. PubMed ID: 31527696
[TBL] [Abstract][Full Text] [Related]
8. CRISPR/Cas9 nickase mediated targeting of urokinase receptor gene inhibits neuroblastoma cell proliferation.
Rysenkova KD; Semina EV; Karagyaur MN; Shmakova AA; Dyikanov DT; Vasiluev PA; Rubtsov YP; Rubina KA; Tkachuk VA
Oncotarget; 2018 Jun; 9(50):29414-29430. PubMed ID: 30034627
[TBL] [Abstract][Full Text] [Related]
9. Urokinase type plasminogen activator receptor (uPAR) as a new therapeutic target in cancer.
Montuori N; Pesapane A; Rossi FW; Giudice V; De Paulis A; Selleri C; Ragno P
Transl Med UniSa; 2016 Nov; 15():15-21. PubMed ID: 27896223
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the value of uPAR of serum and tissue on patients with cervical cancer.
Jing J; Zheng S; Han C; Du L; Guo Y; Wang P
J Clin Lab Anal; 2012 Jan; 26(1):16-21. PubMed ID: 24833530
[TBL] [Abstract][Full Text] [Related]
11. Antagonistic anti-urokinase plasminogen activator receptor (uPAR) antibodies significantly inhibit uPAR-mediated cellular signaling and migration.
Duriseti S; Goetz DH; Hostetter DR; LeBeau AM; Wei Y; Craik CS
J Biol Chem; 2010 Aug; 285(35):26878-26888. PubMed ID: 20501655
[TBL] [Abstract][Full Text] [Related]
12. Decreased TIP30 expression promotes tumor metastasis in lung cancer.
Tong X; Li K; Luo Z; Lu B; Liu X; Wang T; Pang M; Liang B; Tan M; Wu M; Zhao J; Guo Y
Am J Pathol; 2009 May; 174(5):1931-9. PubMed ID: 19349353
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic potential of siRNA-mediated targeting of urokinase plasminogen activator, its receptor, and matrix metalloproteinases.
Gondi CS; Rao JS
Methods Mol Biol; 2009; 487():267-81. PubMed ID: 19301652
[TBL] [Abstract][Full Text] [Related]
14. uPA/uPAR downregulation inhibits radiation-induced migration, invasion and angiogenesis in IOMM-Lee meningioma cells and decreases tumor growth in vivo.
Kargiotis O; Chetty C; Gogineni V; Gondi CS; Pulukuri SM; Kyritsis AP; Gujrati M; Klopfenstein JD; Dinh DH; Rao JS
Int J Oncol; 2008 Nov; 33(5):937-47. PubMed ID: 18949356
[TBL] [Abstract][Full Text] [Related]
15. Signaling through urokinase and urokinase receptor in lung cancer cells requires interactions with beta1 integrins.
Tang CH; Hill ML; Brumwell AN; Chapman HA; Wei Y
J Cell Sci; 2008 Nov; 121(Pt 22):3747-56. PubMed ID: 18940913
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of uPAR confirms link in growth and metastasis of osteosarcoma.
Dass CR; Nadesapillai AP; Robin D; Howard ML; Fisher JL; Zhou H; Choong PF
Clin Exp Metastasis; 2005; 22(8):643-52. PubMed ID: 16649073
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of invasion, angiogenesis, tumor growth, and metastasis by adenovirus-mediated transfer of antisense uPAR and MMP-9 in non-small cell lung cancer cells.
Rao JS; Gondi C; Chetty C; Chittivelu S; Joseph PA; Lakka SS
Mol Cancer Ther; 2005 Sep; 4(9):1399-408. PubMed ID: 16170032
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated antisense urokinase-type plasminogen activator receptor gene transfer reduces tumor cell invasion and metastasis in non-small cell lung cancer cell lines.
Lakka SS; Rajagopal R; Rajan MK; Mohan PM; Adachi Y; Dinh DH; Olivero WC; Gujrati M; Ali-Osman F; Roth JA; Yung WK; Kyritsis AP; Rao JS
Clin Cancer Res; 2001 Apr; 7(4):1087-93. PubMed ID: 11309361
[TBL] [Abstract][Full Text] [Related]
19. Synergistic down-regulation of urokinase plasminogen activator receptor and matrix metalloproteinase-9 in SNB19 glioblastoma cells efficiently inhibits glioma cell invasion, angiogenesis, and tumor growth.
Lakka SS; Gondi CS; Yanamandra N; Dinh DH; Olivero WC; Gujrati M; Rao JS
Cancer Res; 2003 May; 63(10):2454-61. PubMed ID: 12750266
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
